UN warns Ebola epidemic remains 'massive,' may not yet have peaked despite DRC optimism
While Congo's government cites evidence the outbreak has peaked, UN officials stress the epidemic is still deadly, complex, and months from containment.
United Nations officials said on Tuesday that efforts to contain the Ebola outbreak in eastern Democratic Republic of Congo have begun to show results, but cautioned that the epidemic remains deadly and massive. Julien Harneis, the UN's special Ebola coordinator, told a Geneva press briefing that while "there are some areas of progress," the response continues to see case growth in other regions and the situation would take months to bring under control. The warning comes days after DRC authorities said the outbreak has passed 7,000 cases and suggested that transmission may have peaked in mid-August. The Bundibugyo virus outbreak, declared in May 2026, is now the second-largest Ebola epidemic on record and the fastest-growing, with case fatality rates reaching approximately 47 percent. The virus spread across seven provinces and has killed nearly 3,400 people, but the DRC government noted that some health zones have recorded no new cases for at least three weeks. The disconnect between optimism in Kinshasa and caution from international health authorities reflects uncertainty over whether containment efforts and community engagement are finally slowing transmission, or whether the dynamic remains volatile across the conflict-affected eastern regions where the outbreak is unfolding.
How could this affect you
Traced by who's actually in the path of this — not everyone is.
Likely
If you work in global health emergency response or international aid
A prolonged outbreak spanning months (rather than weeks) would strain funding, personnel, and supply chains already critical across humanitarian crises globally, potentially limiting capacity for other emergencies.
Likely
If you live or work in Central Africa, especially near DRC borders
A slowly-peaking epidemic increases cumulative case numbers and raises the odds of cross-border spillover to Uganda, South Sudan, Rwanda, and CAR, each already dealing with humanitarian or security stress.
Possible
If you invest in or work on infectious disease vaccines and treatments
The absence of approved vaccines or treatments for Bundibugyo virus, combined with a massive ongoing outbreak, could accelerate development timelines and regulatory pathways for candidates currently in trials.
Sources
Every claim here traces back to reporting you can read yourself.
